PTH hormone

Lanske Lab Research Finding Could Influence Treatment of Osteoporosis and Other Diseases

April 17, 2017

Researchers in the Lanske Laboratory at Harvard School of Dental Medicine (HSDM) in collaboration with the Rosen Laboratory at Maine Medical Center have been studying the function of Parathyroid hormone (PTH) beyond its well-known role in maintaining calcium homeostasis in the body. PTH has been approved for treatment of osteoporosis in humans to induce bone formation.


Intini Lab Research Leads to Collaboration with Boston Children's Hospital Surgeons on Potential Treatments for Craniofacial Malformations

April 5, 2017

A recent research finding published in Stem Cell Reports could potentially lead to therapies that address craniofacial malformations in children. Craniofacial malformations are deformities that affect a child’s head and facial bones—disorders such as cleft palate, or craniosynostosis that are present at birth.

2017 Apr 20

HSDM Sesquicentennial Scientific Symposium

9:00am to 5:00pm


Research Education Building Lobby & Auditorium


April 20, 2017  9am-3pm (REB Auditorium)
Celebrating 150 Years of Science at HSDM

Research talks by Drs. Andreia Ionesco, Sook-Bin Woo, Agnes Berendsen,
Francesca Gori, Gili Naveh, Shigemi Nagai, and Giuseppe Intini.

April 20, 2017  3pm (REB Auditorium) Reception to Follow
Goldhaber Award Lecture

Professor Laurie McCauley presenting,
Osteal Macrophages: Micromanagers of Skeletal Homeostasis


2017 Apr 19

Student Research Day and Annual Giddon Lecture

9:00am to 5:00pm


Research Education Building: Lobby, Auditorium & REB 109

April 19, 2017  9am-3pm (REB Lobby)
Student Research Day
DMD, MMSc, DMSc, PhD and Postdoctoral Fellows’ poster presentations.
April 19, 2017  3pm (REB Auditorium) Reception to Follow
Annual Lecture in Behavioral Medicine and Dentistry
Professor Emeritus Donald Giddon presenting,
Revolution Redux, 150 Years After Beginning The First University Dental School

2016-2017 Dean’s Scholars Announced

2016-2017 Dean’s Scholars Announced

September 13, 2016

Today, the HSDM community gathered to celebrate the newest Dean's Scholars. Dean Bruce Donoff presented the awards at a special tea held in the Research and Education Building. The Dean’s Scholars program provides dedicated time and funding for outstanding individuals to develop and refine the skills necessary for future success in academics and research. This years’ award recipients are:

HSDM to Lead Program in Rwanda on Ethics Training in Health Research

HSDM to Lead Program in Rwanda on Ethics Training in Health Research

July 19, 2016

By Ellen Garnett
Dr. Bernard Friedland, assistant professor in Oral Medicine, Infection and Immunity, recently received a National Institutes of Health (NIH) Fogarty International Center Award for his research project, “Development Initiative for Ethical Review and Oversight of Health Research Involving Human Subjects in Rwanda.”

New Study by HSDM Researchers May Have Implications for Treating Osteoporosis

New Study by HSDM Researchers May Have Implications for Treating Osteoporosis

June 30, 2016

As we age, every stumble or fall comes with a risk—a risk that is even greater for those ten million people in the U.S. who have osteoporosis, a skeletal disease characterized by low bone mass, poor bone quality and fractures. Each year, 1.5 million bone fractures are attributed to osteoporosis, including 350,000 hip fractures. But hip or other fractures in older and osteoporotic patients do not heal easily and this often leads to significant impairments in daily life, and even death.

Professor Malcolm Whitman Gets Backing of Allied-Bristol Life Sciences (ABLS)

Professor Malcolm Whitman Gets Backing of Allied-Bristol Life Sciences (ABLS)

July 6, 2015

Dr. Malcolm Whitman, PHD87, HSDM professor of developmental biology, and Tracy Keller, SM87, PHD96, an instructor in the Department of Developmental Biology, have identified a chemical compound based on an active ingredient in the root of the blue evergreen hydrangea (Dichroa febrifuga), that could lead to treatment of chronic fibrotic and autoimmune diseases. The root has been used in traditional Chinese medicine for centuries. Whitman and Keller identified the mechanism of action, halofuginone (HF), found within the root.